Applied DNA Sciences, Inc. (APDN) Comparison with companies in other sectors?

Applied DNA Sciences, Inc. has a share price of 519.00K. You can analyze Applied DNA Sciences, Inc. (APDN) competitors across different market sectors through stock heatmaps.

What are APDN's NET and operating margins?

Applied DNA Sciences, Inc. (APDN) operating margin is around -3.44, and net profit margin is approximately -8.25 as of the latest reports.

In what way does APDN's earnings per share (EPS) trend reflect its financial momentum?

Applied DNA Sciences, Inc. (APDN) EPS is 3730.95 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Applied DNA Sciences, Inc. is N/A, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Applied DNA Sciences, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Applied DNA Sciences, Inc. like P/E which is -0.29, P/B which is 0.90, and PEG which is 0.002. Compare them with sector averages to evaluate if the stock is priced fairly.

Applied DNA Sciences, Inc.

APDN•NASDAQ

Healthcare

Medical - Diagnostics & Research

$5.05

$-0.20(-3.81%)

Fundamental Analysis of Applied DNA Sciences, Inc. (APDN)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$3730.95

P/E Ratio

ROE

-2.81%

Net Margin

-8.25%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$2.62M

Shares OutstandingTotal number of shares issued

$519.00K

Book Value/ShareNet worth per share

$5.77

Revenue/ShareAnnual revenue per share

$2.14

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$3730.95

Net MarginNet income as percentage of revenue

-825.19%

Operating MarginOperating income as percentage of revenue

-344.11%

ROEReturn on shareholders' equity

-281.09%

ROAReturn on total assets

-239.96%

ROCEReturn on capital employed

-117.07%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-7.87

Cash/ShareCash and equivalents per share

$3.85

FCF YieldFree cash flow as percentage of market cap

-527.04%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for APDNFinancial Ratios Analysis details for APDN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for APDNSector Benchmarking details for APDN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Applied DNA Sciences, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Applied DNA Sciences, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Applied DNA Sciences, Inc.'s unique business strengths and challenges.

Key Financial Metrics for Applied DNA Sciences, Inc.

For Applied DNA Sciences, Inc., essential financial indicators include EPS 3730.95, PE -, and ROE -2.81. These key ratios reveal insights into Applied DNA Sciences, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Applied DNA Sciences, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Applied DNA Sciences, Inc.

Metrics like Net Margin -825.19% and ROA -239.96% shed light on how well Applied DNA Sciences, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Applied DNA Sciences, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Applied DNA Sciences, Inc.

Using ratios such as P/B Ratio 0.90 and PEG Ratio 0.002, investors can assess whether Applied DNA Sciences, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Applied DNA Sciences, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Applied DNA Sciences, Inc.

Financial health indicators, such as Debt/Equity Ratio 0.05 and Cash Flow $-7.87, provide a snapshot of Applied DNA Sciences, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Applied DNA Sciences, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Applied DNA Sciences, Inc.

Investing in Applied DNA Sciences, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Applied DNA Sciences, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;